Shaw Christine 4
4 · GenMark Diagnostics, Inc. · Filed Feb 25, 2021
Insider Transaction Report
Form 4
Shaw Christine
VP, Assay Development
Transactions
- Sale
Common Stock
2021-02-24$19.12/sh−259$4,952→ 105,621 total - Sale
Common Stock
2021-02-23$19.35/sh−166$3,212→ 105,880 total
Footnotes (1)
- [F1]The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted restricted stock units.